<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04289090</url>
  </required_header>
  <id_info>
    <org_study_id>1281970-5</org_study_id>
    <nct_id>NCT04289090</nct_id>
  </id_info>
  <brief_title>Sevoflurane Versus Propofol on Optic Nerve Sheath Diameter During Anesthesia in Steep Trendelenburg Position</brief_title>
  <official_title>Sevoflurane Versus Propofol on Optic Nerve Sheath Diameter During Anesthesia in Steep Trendelenburg Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>State University of New York - Downstate Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>State University of New York - Downstate Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will prospectively compare change in ONSD during anesthesia with sevoflurane-only versus
      anesthesia with propofol-only in two groups of patients undergoing urologic and gynecologic
      surgery in the steep Trendelenburg position. We hypothesize that there will be a significant
      decrease in the size of ONSD during transition from sevoflurane-only anesthesia to
      propofol-only anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Steep Trendelenburg positioning is required for optimal surgical exposure for certain
      procedures, including robotic assisted laparoscopic urologic and gynecologic procedures. The
      position is associated with increased intracranial pressure (ICP) and its complications such
      as post-operative vision loss (POVL) and post-op delirium [Lee 2013]. Therefore, it is
      essential to measure ICP intra-operatively in order to implement real time management. The
      gold standard for ICP measurement is an external ventricular drain (EVD). However, it is
      invasive and not practical for the majority of non-neurosurgical procedures. Trans-ocular
      ultrasound measurement of Optic nerve sheath diameter (ONSD) is a non-invasive alternative
      for ICP measurement [Tayal et al 2007; Nash et al 2016]. Compared to EVD it is non-invasive,
      less expensive and efficient. It has been validated as a screening tool for identification of
      patients with elevated ICP who required treatment in several larger studies [Nash et al 2016;
      Blecha et al 2017]. During these procedures prior pre-cautions to prevent increased ICP
      focused on fluid restriction/selection. Ultrasound measurement of ONSD has not been routinely
      employed. Furthermore, consideration has rarely been given to the benefits of total
      intravenous anesthesia (TIVA) rather than volatile anesthetics for anesthesia maintenance
      during these procedures. Considering the complications of increased ICP, sonographic
      measurement could prove to be a practical method to efficiently monitor the ICP surrogate
      [Riaz et al 2016; Nash et al 2016; Banerjee et al 2017]. This study will perform
      intra-operative sonographic ONSD measurements in order to compare the change in ONSD during
      transition from inhalational maintenance anesthesia (using sevoflurane) to total intravenous
      anesthesia (TIVA) using propofol.

      While other studies have demonstrated that the use of pneumoperitoneum and steep
      Trendelenburg positioning can lead to an increase in ICP as determined by use of ONSD (Robba
      et al. 2016), this study describes the added role of ONSD measurement for guiding the choice
      of anesthesia maintenance (TIVA vs sevoflurane) during surgery in the steep-Trendelenburg
      position.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2020</start_date>
  <completion_date type="Anticipated">January 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 17, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A will begin anesthesia maintenance with sevoflurane-only, then will be switched after 30 minutes to anesthesia with propofol-only. Group B will begin anesthesia with propofol-only then will be switched to sevoflurane-only.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Group A will begin anesthesia maintenance with sevoflurane-only, then will be switched after 30 minutes to anesthesia with propofol-only. Group B will begin anesthesia with propofol-only then will be switched to sevoflurane-only.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Sevoflurane Versus Propofol on Optic Nerve Sheath Diameter During Anesthesia in Steep Trendelenburg Position</measure>
    <time_frame>2 years</time_frame>
    <description>1. Percentage of change in ONSD during anesthesia with sevoflurane-only versus propofol-only in two groups of patients undergoing urologic and gynecologic surgery in the steep Trendelenburg position.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Percentage of Change in ONSD During Anesthesia With Sevoflurane Versus Propofol in Two Groups of Patients</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group A will begin anesthesia maintenance with sevoflurane-only, then will be switched after 30 minutes to anesthesia with propofol-only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group B will begin anesthesia with propofol-only then will be switched to sevoflurane-only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane Inhalant Product</intervention_name>
    <description>This study will perform intra-operative sonographic ONSD measurements in order to compare the change in ONSD during transition from inhalational maintenance anesthesia (using sevoflurane) to total intravenous anesthesia (TIVA) using propofol.</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 10 MG/ML</intervention_name>
    <description>This study will perform intra-operative sonographic ONSD measurements in order to compare the change in ONSD during transition from inhalational maintenance anesthesia (using sevoflurane) to total intravenous anesthesia (TIVA) using propofol.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients scheduled to undergo surgery in the steep Trendelenburg position at SUNY
        Downstate Medical Center.

        Exclusion Criteria:

        &lt; 18 years old Pregnancy Pre-existing eye disease Prior ophthalmic surgery Inability to
        tolerate steep Trendelenburg position Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gina Subtirelu, MD</last_name>
    <phone>516-241-5038</phone>
    <email>gina.subtirelu@downstate.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mauricia C Victor, MS,MPH</last_name>
    <phone>718-270-1937</phone>
    <email>mauricia.victor@downstate.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>SUNY Downstate Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203-2098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lee LA. Perioperative visual loss and anesthetic management. Curr Opin Anaesthesiol. 2013 Jun;26(3):375-81. doi: 10.1097/ACO.0b013e328360dcd9. Review.</citation>
    <PMID>23614957</PMID>
  </reference>
  <reference>
    <citation>Moretti R, Pizzi B. Ultrasonography of the optic nerve in neurocritically ill patients. Acta Anaesthesiol Scand. 2011 Jul;55(6):644-52. doi: 10.1111/j.1399-6576.2011.02432.x. Epub 2011 Apr 4. Review.</citation>
    <PMID>21463263</PMID>
  </reference>
  <reference>
    <citation>Blecha S, Harth M, Schlachetzki F, Zeman F, Blecha C, Flora P, Burger M, Denzinger S, Graf BM, Helbig H, Pawlik MT. Changes in intraocular pressure and optic nerve sheath diameter in patients undergoing robotic-assisted laparoscopic prostatectomy in steep 45° Trendelenburg position. BMC Anesthesiol. 2017 Mar 11;17(1):40. doi: 10.1186/s12871-017-0333-3.</citation>
    <PMID>28284189</PMID>
  </reference>
  <reference>
    <citation>Tranquart F, Bergès O, Koskas P, Arsene S, Rossazza C, Pisella PJ, Pourcelot L. Color Doppler imaging of orbital vessels: personal experience and literature review. J Clin Ultrasound. 2003 Jun;31(5):258-73. Review.</citation>
    <PMID>12767021</PMID>
  </reference>
  <reference>
    <citation>Riaz R, Khuba S, Shamim R, Patro A. Ultrasonographic optic nerve sheath diameter measurement in overweight parturient with intracranial tumour: Guiding choice of anaesthesia. Indian J Anaesth. 2016 Oct;60(10):775-777.</citation>
    <PMID>27761045</PMID>
  </reference>
  <reference>
    <citation>Banerjee A, Bala R, Saini S. Ultrasonographic measurement of optic nerve sheath diameter: A point of care test helps in prognostication of Intensive Care Unit patients. Indian J Anaesth. 2017 Mar;61(3):262-265. doi: 10.4103/ija.IJA_473_16.</citation>
    <PMID>28405042</PMID>
  </reference>
  <reference>
    <citation>Tayal VS, Neulander M, Norton HJ, Foster T, Saunders T, Blaivas M. Emergency department sonographic measurement of optic nerve sheath diameter to detect findings of increased intracranial pressure in adult head injury patients. Ann Emerg Med. 2007 Apr;49(4):508-14. Epub 2006 Sep 25.</citation>
    <PMID>16997419</PMID>
  </reference>
  <reference>
    <citation>Kim JY, Min HG, Ha SI, Jeong HW, Seo H, Kim JU. Dynamic optic nerve sheath diameter responses to short-term hyperventilation measured with sonography in patients under general anesthesia. Korean J Anesthesiol. 2014 Oct;67(4):240-5. doi: 10.4097/kjae.2014.67.4.240. Epub 2014 Oct 27.</citation>
    <PMID>25368781</PMID>
  </reference>
  <reference>
    <citation>Robba C, Cardim D, Donnelly J, Bertuccio A, Bacigaluppi S, Bragazzi N, Cabella B, Liu X, Matta B, Lattuada M, Czosnyka M. Effects of pneumoperitoneum and Trendelenburg position on intracranial pressure assessed using different non-invasive methods. Br J Anaesth. 2016 Dec;117(6):783-791.</citation>
    <PMID>27956677</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

